🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BLF
$BLFS
🔒 US EquitiesBioLife Solutions, Inc.
AVG HISTORICAL GAP
-1.14%
MAX GAP RECORD
-15.66%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BLFS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BLFS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+1.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-5.71%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
+4.54%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-0.63%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
+6.44%
|
| Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN) |
+7.54%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-0.75%
|
| Aug 08, 2024 Earnings Release 2024-08-08 (AFTER CLOSE) |
+7.65%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.8%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (2)
📖 Intelligence Summary
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗